Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

HBIO

HBIO News

Newswire

06:31

Harvard Bioscience: Valuation and Outlook for Buying Opportunity

02:18

Harvard Bioscience Expects $22.5M-$24.5M Q4 Revenue Amid Two-Year High Backlog and Expanded Product Rollouts

07:07

Harvard Bioscience Q3 rev $20.6mln, gross margin 58.4%, expects to refinance debt.

08:23

Harvard Bioscience reports Q1 revenue of $24.2mln, up 10% YoY.

08:04

Harvard Bioscience Announces Q3 2025 Earnings Release and Conference Call on November 6, 2025.

View More

About HBIO

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More